Doctors test cutting radiation for Fast-Responding HPV throat cancers
NCT ID NCT03215719
Summary
This study is testing if doctors can safely lower the dose of radiation and chemotherapy for people with HPV-positive throat cancer who show a good response halfway through treatment. The goal is to see if patients who get less treatment have similar cancer control and survival rates, while potentially experiencing fewer long-term side effects. The study will follow 120 patients for two years to track if their cancer progresses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New York University School of Medicine
RECRUITINGNew York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.